Entry |
|
Name |
Edaglitazone sodium (USAN) |
Formula |
C24H19N2O4S2. Na
|
Exact mass |
486.0684
|
Mol weight |
486.54
|
Structure |
|
Class |
|
Efficacy |
Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) gamma agonist |
Comment |
Treatment of type 2 diabetes
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione
D03941 Edaglitazone sodium
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione
D03941 Edaglitazone sodium
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D03941 Edaglitazone sodium (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C1y C 33.8533 -21.0740
2 C5x C 33.8533 -22.4863
3 N1x N 35.1949 -22.9099 #-
4 C5x C 36.0423 -21.7801
5 S2x S 35.1949 -20.6503
6 O5x O 37.4545 -21.7801
7 O5x O 32.7234 -23.3336
8 C1b C 32.6528 -20.3679
9 C8y C 31.4524 -21.0740
10 C8y C 30.2236 -20.3779
11 C8y C 29.0770 -21.0939
12 C8y C 29.0179 -22.5061
13 C8x C 30.2466 -23.2023
14 C8x C 31.4639 -22.4863
15 O2a O 27.8172 -23.1725
16 C1b C 26.6400 -22.4661
17 C1b C 25.4050 -23.1515
18 C8y C 24.1622 -22.4062
19 C8y C 24.2037 -21.0036
20 O2x O 22.8840 -20.5325
21 C8y C 22.0282 -21.6419
22 N5x N 22.8188 -22.7987
23 C1a C 25.3532 -20.2184
24 C8y C 20.6491 -21.6728
25 C8x C 19.9003 -20.4412
26 C8x C 18.4884 -20.4732
27 C8x C 17.8101 -21.7118
28 C8x C 18.5589 -22.9435
29 C8x C 19.9708 -22.9116
30 S2x S 29.8970 -19.0660
31 C8x C 28.5484 -18.9713
32 C8x C 28.0417 -20.2246
33 Z Na 36.1200 -24.2900 #+
BOND 36
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 4 6 2
7 2 7 2
8 8 1 1
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 9 14 1
16 12 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 1
23 21 22 2
24 18 22 1
25 19 23 1
26 21 24 1
27 24 25 2
28 25 26 1
29 26 27 2
30 27 28 1
31 28 29 2
32 24 29 1
33 10 30 1
34 30 31 1
35 31 32 2
36 11 32 1
|